Publications by authors named "Sonia Fox"

Claim this Profile
T
The REFRACT trial: implementation of Bayesian power priors in a randomised, sequential phase II adaptive platform trial.
Charlotte Gaskell, Kim Linton, Mark Bishton, Graham McIlroy, Siân Lax, Sonia Fox

BMC Med Res Methodol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial.
Graham McIlroy, Charlotte Gaskell, Aimee Jackson, Emily Yafai, Rachel Tasker, Sonia Fox

BMC Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of the blood cancer polycythemia vera with ruxolitinib in the MAJIC-PV study: a plain language summary.
Claire N Harrison, Sonia Fox, Rebecca Boucher, Mary Frances McMullin, Adam J Mead

Future Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial.
Graham McIlroy, Siân Lax, Charlotte Gaskell, Aimee Jackson, Malcolm Rhodes, Sonia Fox

BMC Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis.
Zijian Fang, Giuditta Corbizi Fattori, Thomas McKerrell, Rebecca H Boucher, Aimee Jackson, Sonia Fox

Nat Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes.
Justin Loke, Vinit Upasani, Charlotte Gaskell, Sonia Fox, Rachel Fletcher

Br J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial.
Claire N Harrison, Jyoti Nangalia, Rebecca Boucher, Aimee Jackson, Christina Yap, Sonia Fox

J Clin Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial.
Richard Dillon, Shanna Maycock, Aimee Jackson, Sonia Fox, Sylvie Freeman

BMC Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous genetic and non-genetic mechanisms contribute to response and resistance to azacitidine monotherapy.
Vasiliki Symeonidou, Marlen Metzner, Batchimeg Usukhbayar, Aimee E Jackson, Sonia Fox

EJHaem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapy.
Justin Loke, Marlen Metzner, Rebecca Boucher, Aimee Jackson, Louise Hopkins, Sonia Fox

Br J Haematol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib.
Jennifer M O'Sullivan, Angela Hamblin, Christina Yap, Sonia Fox, Rebecca Boucher

Blood· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial re-investment to build better research for better impact.
Thomas A Fox, Gillian A Horne, Charles Craddock, Gordon Cook, Stephen O'Brien, Sonia Fox

Lancet· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single arm phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancers.
Jim Murray, Guy Pratt, Abe Jacob, Fiona Clark, Rachel Blundred, Sonia Fox

Contemp Clin Trials Commun· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The STELLAR trial protocol: a prospective multicentre trial for Richter's syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease.
Niamh Appleby, Toby A Eyre, Maite Cabes, Aimee Jackson, Rebecca Boucher, Sonia Fox

BMC Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.
Claire N Harrison, Adam J Mead, Anesh Panchal, Sonia Fox, Christina Yap

Blood· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis